GLOSA LUB KOMENTARZ PRAWNICZY
Zapobieganie zachorowaniom na grypę – z polskiej perspektywy
Lidia Bernadeta Brydak 1 , Aneta Nitsch-Osuch 21. Department of Influenza Research. National Influenza Centre, National Institute of Public Health – National Institute of Hygiene, Warsaw, Poland; Department of Immunology, Faculty of Biology, University of Szczecin, Szczecin, Poland; 3Department of Family Medicine, Warsaw Medical University, Poland
2. Department of Immunology, Faculty of Biology, University of Szczecin, Szczecin, Poland; 3Department of Family Medicine, Warsaw Medical University, Poland
Opublikowany: 2014-02-03
DOI: 10.5604/17322693.1088062
GICID: 01.3001.0003.1188
Dostępne wersje językowe: pl en
Wydanie: Postepy Hig Med Dosw 2014; 68 : 137-144
Abstrakt
Przypisy
- 1. ACIP. Prevention and Control of Influenza. Recommendations of theAdvisory Committee on Immunization Practices (ACIP). Center for DiseaseControl and Prevention. Morb. Mortal. Weekly Rep., 2000; 49: 3-20
Google Scholar - 2. ACIP. Prevention and Control of Influenza with Vaccines: Recommendationsof the Advisory Committee on Immunization Practices(ACIP). Morb. Mortal. Weekly Rep., 2010; 59: 1-62
Google Scholar - 3. ACIP. Prevention and Control of Influenza with Vaccines: Recommendationsof the Advisory Committee on Immunization Practices(ACIP). 2011. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6033a3.htm (accessed November 5, 2012)
Google Scholar - 4. ACIP. Prevention and Control of Influenza with Vaccines: Recommendationsof the Advisory Committee on Immunization Practices(ACIP). 2012. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6022a3.htm (accessed November 5, 2012)
Google Scholar - 5. Beyer W., Palache A.M., Sprenger M.J., Hendriksen E., Tukker J.J.,Darioli R., van der Water G.L., Masurel N., Osterhaus A.D.: Effect ofrepeated annual influenza vaccination on vaccine sero-response inyoung and elderly adults. Vaccine, 1996; 14: 1331-1339
Google Scholar - 6. Brydak L.B.: Characteristics of Influenza Viruses (A/H3N2) Adaptedto Low Temperature Replication. National Institute for Hygiene(Dissertation qualifying for Associate Professor) Warsaw, 1990,1-135 (in Polish)
Google Scholar - 7. Brydak L.B.: Influenza, pandemic flu myth or a real threat? Rhythm,2008: 1-492 (in Polish)
Google Scholar - 8. Brydak L.B.: Vaccinations against influenza. Leki WspółczesnejTerapii, Encyklopedia dla lekarzy i farmaceutów. 2010, Ed. 20: 907- 908 (in Polish)
Google Scholar - 9. Brydak L.B.: Influenza – an age old problem. Hygeia Public Health,2012; 47: 1-7 (in Polish)
Google Scholar - 10. Brydak L., Bialek J., Rudnicka H.: Seroconversion assessment inbilleted Military Medical University student group after antiinfluenzasubunit vaccinations in 1993/1994 in Poland. Antiinfect. DrugsChemother., 1997; 15: 13-16
Google Scholar - 11. Brydak L.B., Calbecka M.: Immunogenicity of influenza vaccinein patients with hemato-oncological disorders. Leuk. Lymphoma,1999; 32: 369-374
Google Scholar - 12. Brydak L.B., Fracka B., Maruszak M., Rudnicka H., Nachman S.A.:Influenza immunization for children with bronchopulmonary dysplasiain Poland. Pediatr. Infect. Dis. J., 1997; 16: 538-539
Google Scholar - 13. Brydak L.B., Gall W., Semkow R.: Comparative anti-influenza vaccinationof some groups of the population with vaccine differing invirus purification level. Arch. Immunol. Ther. Exp., 1987, 35: 201-206
Google Scholar - 14. Brydak L.B., Guzy J., Starzyk J., Machała M., Góźdź S.S.: Humoralimmune response after vaccination against influenza in patientswith breast cancer. Support. Care Cancer, 2001; 9: 65-68
Google Scholar - 15. Brydak L.B, Hryniewicz H.J., Machała M.: Humoral response toinfluenza vaccination in HIV-infected patients. Clin. Drug Invest.1999, 17: 441-449
Google Scholar - 16. Brydak L.B., Machała M., Centkowski P., Warzocha K, Biliński P.:Humoral response to hemagglutinin components of influenza vaccinein patients with non-Hodgkin malignant lymphoma. Vaccine,2006: 24: 6620-6623
Google Scholar - 17. Brydak L.B., Machała M., Laguna P., Rokicka-Milewska R.: Antibodyresponse to influenza vaccination in splenectomized patientsin Poland. J. Clin. Immunol., 2004; 24: 225-236
Google Scholar - 18. Brydak L.B., Machała M., Myśliwska J., Myśliwski A, TrzonkowskiP.: Immune response to influenza vaccination in an elderly population.J. Clin. Immunol., 2003; 23: 214-222
Google Scholar - 19. Brydak L.B., Rokicka-Milewska R., Jackowska T., Rudnicka H.,Regnery H., Cox N.: Kinetics of humoral response in children withacute lymphoblastic leukemia immunized with influenza vaccine in 1993 in Poland. Leuk. Lymphoma, 1997; 26: 163-169
Google Scholar - 20. Brydak L.B., Rokicka-Milewska R., Klukowska A.: Antibody kineticsin children with hemophilia immunized with influenza vaccinein 1993 in Poland. Int. J. Ped. Hematol. Oncol.,1998; 5: 13-19
Google Scholar - 21. Brydak L.B., Rokicka-Milewska R., Machała M., Jackowska T.,Sikorska-Fic B.: Immunogenicity of subunit trivalent influenza vaccinein children with acute lymphoblastic leukemia. Pediatr. Infect.Dis. J., 1998; 17: 125-129
Google Scholar - 22. Brydak L.B., Roszkowska-Blaim M., Machała M., LeszczyńskaB., Sieniawska M.: Antibody response to influenza immunization intwo consecutive epidemic seasons in patients with renal diseases.Vaccine, 2000; 1: 3280-3286
Google Scholar - 23. Brydak L.B., Roszkowska-Blaim M., Machała M., Leszczyńska B,Sieniawska M.: Immunological response to influenza vaccinationin children with renal failure. Nephrol. Dial. Transplant., 2001; 16:643-644
Google Scholar - 24. Brydak L.B., Skwarczyński T., Machala M.: Antibody responseto influenza vaccination in healthy adults. Viral Immunol., 2004;17: 609-615 25 Ciszewski A., Bilińska Z.T., Brydak L.B.: Influenza vaccination inprevention from coronary events coronary artery disease. FLUCACstudy. Circulation, 2006; 114, suppl.: 4199
Google Scholar - 25. May 2013)
Google Scholar - 26. Ciszewski A., Bilińska Z.T., Brydak L.B., Kepka C., Kruk M., RomanowskaM., Ksieżycka E, Przyluski J, Piotrowski W, Maczyńska R,Ruzyllo W. Influenza vaccination in secondary prevention from coronaryischaemic events in coronary artery disease. FLUCAD study.Eur. Heart J., 2008; 29: 1350-1358
Google Scholar - 27. European Centre for Disease Prevention and Control. www.ecdc.eu (accessed 23 May 2013)
Google Scholar - 28. European Medicines Agency. www.emea.europa.eu (accessed
Google Scholar - 29. Fleming D.M., Elliot A.J.: Estimating the risk population in relationto influenza vaccination policy. Vaccine, 2006; 24: 4378-4385
Google Scholar - 30. Gross P.A., Denning C.R., Gaerlan P.F., Bonelli J., Bernius M., DranS., Monk G., Vassallo M., Quinnan G.V. Jr, Levandowski R., CataruozoloP.E., Wallenstein S.: Annual influenza vaccination: immune responsein patients over 10 years. Vaccine, 1996; 14: 1280-1284
Google Scholar - 31. Jahnz-Różyk K.M., Brydak L.B., Targowski T.: Effect of influenzavaccinations on immune response and serum eotaxin levelin patients with allergic bronchial in Poland. VIIIth InternationalCongress of the Polish Society of Allergology. Int. Rev. Allergol. Clin.Immunol, 2003, 2: 1-24
Google Scholar - 32. Jahnz-Różyk K.M., Brydak L.B., Targowski T., Machała M., PlusaT.: Effect of influenza vaccinations on immune response and serumeotaxin level in patients with allergic bronchial asthma. MediatorsInflamm., 2004; 13: 195-199
Google Scholar - 33. Jahnz-Różyk K.M., Płusa T., Targowski T.: Effect of influenza vaccinationson immune response and serum eotaxin level in patientswith asthma. World Allergy Organization Congress – XVIII ICACI,Vancouver, Canada 7-12 September 2003. J World Allergy Org., P-9-10
Google Scholar - 34. Narodowy Instytut Zdrowia Publicznego. Państwowy ZakładHigieny. www.pzh.gov.pl (accessed 23 May 2013)
Google Scholar - 35. Płusa T., Brydak L.B., Jahnz –Różyk K.M.: Effect of influenzavaccinations on immune response in patiens with bronchial asthmaand COPD. Options for the Control of Influenza. International Conference.Abstract Book, W07P-07, pp. 102-103. Nago City, Okinawa,Japan, 2003, October 7-11
Google Scholar - 36. Smorodintsev A.A., Tushinsky M.D., Drobyshevskoya A.I., KorowinA.A.: Investigation in volunteers infected with influenza virus.Am. J. Med. Sci., 1937, 194: 159-170
Google Scholar - 37. Webster R.G., Granoff A. Encyclopaedia of virology: AcademicPress Harcourt Brace Company Publishers London, San Diega, NewYork, Boston, Sydney, Tokyo, Toronto. 1992, 2, 709-727
Google Scholar - 38. Wiesik-Szewczyk E., Romanowska M., Milenik P., Chwalińska–Sadowska H., Brydak L.B., Olesińska M., Zabek J.: Anti-influenzavaccination in systemic lupus erythematosus patients: an analysisof specific humoral response and vaccination safety. Clin. Rheumatol.,2010; 29: 605-613
Google Scholar - 39. World Health Organization. www.who.int (accessed 23 May2013)
Google Scholar - 40. Wyzgal J., Brydak L.B., Zygier D., Paczek L., Rowiński W., GrochowieckiT.: Study on efficacy of influenza vaccination in renal allograftrecipients. Transplant. Proc., 2002; 34: 572-575
Google Scholar - 41. Życińska K., Romanowska M., Nowak I., Rybicka K., WardynK.A., Brydak L.B.: Antibody response to inactivated subunit influenzavaccine in patients with Wegener’s granulomatosis. J. Physiol.Pharmacol., 2007; Suppl 5, 819-828
Google Scholar